
In today’s briefing:
- 2023 High Conviction – Anycolor (5032) Aiming at TSE Prime and TOPIX – And How!
- Premier Anti-Aging Company: DUO Is Going Down
- Tokyo Electron (8035) | Huge Upside if Management Hit Targets
- Sa Sa Intl (178 HK): Is It Too Late to Buy Now?
- Fujifilm: An Inspiring Transformation Story
- Kakao Corp: FTC Going After Chairman Kim Beom-Su’s K Cube Holdings
- Taiwan Dual-Listings: Premiums Bounced… And Have Now Declined Again
- Lotte Shopping: A Deep Value Stock Poised for a Turnaround
- Askul Q2 23 Results Reaction: B2B Growth and B2C Cost Savings Drive Solid Quarter
- Zydus Lifesciences (ZYDUSLIF IN): New Launches Aid US Business; India Business Continued to Progress
2023 High Conviction – Anycolor (5032) Aiming at TSE Prime and TOPIX – And How!
- “VTuber” (Virtual Youtuber) animated influencer company Anycolor (5032 JP) was listed on 8 June 2022 at ¥1530. The stock popped 214% on Day1.It is up another 60% since then.
- Today Anycolor reported Q2 earnings (result, presentation) and revised its full-year forecast to 30 April. Revenues will be +7-18% vs forecast, OP +18-39%, NP +15-39%. Price is 43x forecast EPS.
- The company also announced it is preparing a Section Transfer application, but gave little more info. So we dig into what THAT means.
Premier Anti-Aging Company: DUO Is Going Down
- Premier Anti-Aging (4934 JP) shares rose 6.1% today following a massive earnings miss and a substantial downgrade to FY23 guidance.
- This is perhaps due to low liquidity and depressed prices as the share price dropped more than 85% since July last year.
- We think there’s more downside to the stock, especially with DUO about to hit the bottom of the barrel and CANADEL and Clayence struggling to maintain growth momentum.
Tokyo Electron (8035) | Huge Upside if Management Hit Targets
- Tokyo Electron is a structural growth stock that has fallen by 31% YTD reflecting near term risks to growth and margins
- We believe that the digitization of society has only just begun and that data volumes will grow exponentially
- We analyse TEL’s core value drivers – revenue, margins, risk and reinvestment – and see 38% upside
Sa Sa Intl (178 HK): Is It Too Late to Buy Now?
- We think Sa Sa International Hldgs (178 HK)‘s risk-return payoff still look favourable even after the recent rally, which rides on the expectations of HK-mainland China border opening.
- Assuming net profit returns to 70% of pre-pandemic level in FY25, and applying a peak PER of 25x over 2011-2018, its share price still has 63% upside.
- Release of pent-up demand, stabilisation of gross margin trend, improved cost dynamics and manageable financial position are all positive factors for Sa Sa.
Fujifilm: An Inspiring Transformation Story
- Established as a domestic photographic film manufacturing company, Fujifilm has successfully evolved into a healthcare company with majority revenue earned from medical and life science related businesses.
- Fujifilm is now a leading player in Bio CDMO market through a combination of acquisitions and in-house developed capabilities. The company has gained recognition among leading pharmaceutical companies.
- We think there is further upside to Fujifilm’s valuation multiples as the market still values the stock as an image/photography company and not in line with healthcare peers.
Kakao Corp: FTC Going After Chairman Kim Beom-Su’s K Cube Holdings
- On 15 December, it was announced that Korea’s FTC decided to refer K Cube Holdings (KCH) to the prosecution over alleged illegal execution of voting rights to Kakao companies.
- This could signal that the financial regulators may become more forceful in enforcing numerous other regulatory pressures on Kakao Corp and its affiliated companies to reduce their monopolistic business practices
- Our NAV valuation of Kakao Corp suggests NAV per share of 45,942 won, which is 17% lower than current price.
Taiwan Dual-Listings: Premiums Bounced… And Have Now Declined Again
- TSMC — Small premium currently, recent trading range appears unaffected by Buffett investment
- UMC — Bounced from discount to premium, now at a discount again
- ChipMOS — Bounced from discount to premium, now back to a decent discount
Lotte Shopping: A Deep Value Stock Poised for a Turnaround
- Lotte Shopping is a deep value stock poised for a turnaround.
- Lotte Shopping has clear turnaround catalysts, cheap valuations, and a solid technical setup.
- Perhaps the most important catalysts for Lotte Shopping include getting rid of the most restrictions/social distancing measures related to COVID-19 which have been in place in the past three years.
Askul Q2 23 Results Reaction: B2B Growth and B2C Cost Savings Drive Solid Quarter
- Results for Q2 were better than we expected as B2B sales growth remained robust whilst cost savings on the consumer side boosted margins
- A rather robust decline in revenue for Lohaco is the only negative that stands out but this was partially anticipated whilst the corresponding cost savings are a boon
- An 11% increase in operating profit for Q2 offsets weakness from the previous report and puts the company on track to meet guidance for full-year growth
Zydus Lifesciences (ZYDUSLIF IN): New Launches Aid US Business; India Business Continued to Progress
- In Q2FY23, Zydus Lifesciences Ltd (ZYDUSLIF IN) recorded 16% y/y and 10% q/q growth in the U.S. formulation business, mainly driven by new launches including gRevlimid.
- India formulation business continued to progress well, with market share gain in key therapies including cardiovascular, gynecology, respiratory, and gastro intestinal on a y/y basis.
- Zydus remains confident to achieve 20% plus EBITDA margin for the current fiscal, backed by growth visibility across key businesses, coupled with various cost optimization initiatives.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars